GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $61,000 | 0.0% | 1,405 | 0.0% | 0.02% | +9.5% |
Q1 2022 | $61,000 | -1.6% | 1,405 | 0.0% | 0.02% | -4.5% |
Q4 2021 | $62,000 | +169.6% | 1,405 | +132.2% | 0.02% | +144.4% |
Q3 2021 | $23,000 | -4.2% | 605 | 0.0% | 0.01% | -25.0% |
Q2 2021 | $24,000 | +9.1% | 605 | 0.0% | 0.01% | -7.7% |
Q1 2021 | $22,000 | 0.0% | 605 | 0.0% | 0.01% | -7.1% |
Q4 2020 | $22,000 | -71.1% | 605 | -70.2% | 0.01% | -75.0% |
Q3 2020 | $76,000 | -8.4% | 2,031 | 0.0% | 0.06% | -15.2% |
Q2 2020 | $83,000 | +13.7% | 2,031 | +6.4% | 0.07% | -9.6% |
Q1 2020 | $73,000 | – | 1,909 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |